Join the hundreds of thousands in my email community for the latest news, insight, and more
Leave this field empty if you're human:
The Latest
Learn
Books
About
JOIN MY EMAIL COMMUNITY:
THE LATEST
Blog
Videos
Recipes
Products
Podcast
Media
Your Success
Chimera
Latest Blog Post »
Latest Video »
Latest Chimera Post »
LEARN
Focus Areas
Carb Content of Common Foods
Disconnection Syndrome
Frequently Asked Questions
Gluten-Associated Cross-Reactive Foods
Gluten-Containing Products
Gluten-Free Foods
Glycemic Index
Guides
Resources
Scientific Research Database
Focus Topics
ADD/ADHD
Alzheimer's and Dementia
Autism Spectrum Disorder
Coronavirus
Diabetes
Exercise
Gluten-Free
GMO
Ketogenic
Low-Carb
Magnesium
Mental Health
Multiple Sclerosis
Parkinson's Disease
Pregnant and Nursing
Sleep
Stress
Supplements
Uric Acid
Vegetarian
Weight Loss
BOOKS
All Books
Brain Defenders
Drop Acid
Brain Maker
Brain Wash
Grain Brain
The Grain Brain Whole Life Plan
The Grain Brain Cookbook
NEW BOOK
Brain Defenders
In Brain Defenders, David Perlmutter, MD, introduces a revolutionary understanding of neurodegenerative dise...
Learn More »
ABOUT
Meet Dr. David Perlmutter
Meet Dr. Austin Perlmutter
Professional Appearances
Professional Bookings
Contact
David Perlmutter, MD
Meet America’s Neurologist™
The Latest
Blog
Videos
Recipes
Products
Podcast
Media
Your Success
Chimera
Learn
Focus Areas
Carb Content of Common Foods
Disconnection Syndrome
Frequently Asked Questions
Gluten-Associated Cross-Reactive Foods
Gluten-Containing Products
Gluten-Free Foods
Glycemic Index
Guides
Resources
Scientific Research Database
Books
All Books
Brain Defenders
Drop Acid
Brain Maker
Brain Wash
Grain Brain
The Grain Brain Whole Life Plan
The Grain Brain Cookbook
About
Meet Dr. David Perlmutter
Meet Dr. Austin Perlmutter
Professional Appearances
Professional Bookings
Contact
Uric Acid Deep Dive, How Much Fruit Is Too Much, Alcohol, Benefits of Tart Cherries + What Metabolic Syndrome Can Tell Us About Longevity
Join the hundreds of thousands in my email community for the latest news, insight, and more
Leave this field empty if you're human:
